Insights / Consumer / CPG
Field note

DTC and CPG mid-market M&A multiples — Q2 2026.

The Q2 2026 read on mid-market consumer-brand M&A: where multiples actually sit by category, what the public-comparable cohort tells us about private-market pricing, and the operating drivers behind the spread between premium and commodity exposure.

I track DTC and CPG mid-market M&A multiples every quarter, and the Q2 2026 read is the cleanest cohort I have seen since the pandemic distortion cleared. Capstone Partners has the consumer-industry median at 9.2x EV/EBITDA — the lowest in their ten years of tracking — with a meaningful spread between strategic and sponsor buyers and a wider category-level dispersion underneath the median. The public comparables tell the same story from a different angle: e.l.f. Beauty's $1.6B fiscal-2026 revenue at 70.7% gross margin sits in the same operating envelope as the brands sponsors are paying 11-15x for, while Olaplex has compressed from a $704M revenue, 50%-operating-margin peak to $423M revenue at 1.6% operating margin in three years. The category-level decoupling is real, the operating drivers are nameable, and the lending environment that frames the underwriting has compressed roughly 170 basis points off the Q1 2024 peak. Here is the working read.

01 The headline read — Q2 2026 consumer multiples

The most important single number for mid-market consumer M&A in Q2 2026 is Capstone Partners' median consumer-industry EV/EBITDA at 9.2x. That number reflects 2025 deal activity in the lower mid-market and is the lowest in the ten years Capstone has tracked the data. It is well below the 2021-2022 peak where mid-teens multiples were common for any reasonably-positioned consumer brand, and modestly below the long-run mid-cycle average for the category. The compression is the story; the level is the operating reality.

Underneath the 9.2x, the spread between sponsor and strategic buyers is the second number worth knowing. Sponsors are paying a median 10.4x EBITDA; strategics are paying 8.6x. That ~2-turn premium for sponsor processes is wider than the historical norm and is being driven by record private-equity dry powder competing for a smaller pool of acquirable assets — Cherry Bekaert and Simmons & Simmons both call this out as a 2025-2026 defining feature. Strategics, who tend to underwrite to nearer-term EPS and integration risk, are not equally willing to bid up.

CIBC's US Middle Market Monitor for Q1 2026 puts the lower-middle-market consumer-products subset at 7.2x EBITDA average — slightly above pre-COVID levels but with a notable 22% decline in deal volume from 2024 to 2025 (1,056 to 829 transactions). The volume drop matters as much as the level: it tells you that bid-ask spreads at the lower end of the band are still wide enough to keep deals from closing. PCE Investment Bankers reports consumer-and-retail LTM median EBITDA multiples at 8.76x with revenue multiples rising from 1.22x to 1.33x — the revenue-multiple rise specifically attributable to brands with "durable demand and clear differentiation," not blanket category strength.

The 9.2x median is the lowest in ten years of Capstone's tracking. Pricing has normalised, not collapsed — but the bands underneath the median have decoupled meaningfully.
— From the Q2 2026 desk review, May 2026

02 Where the categories have decoupled

The cohort-level numbers above mask material variance by sub-sector, and the variance has widened. Beauty and personal care continues to anchor the top end of the band: Capstone's YTD 2025 average for the category was 14.9x EV/EBITDA, roughly five turns above the broader consumer average. The pet sector, which had averaged 14.5x across 2022 through YTD 2025, compressed materially in H1 2025 — PE platform medians dropped from 16.8x in 2024 to 12.2x in H1 2025. That four-and-a-half-turn drop in twelve months tracks the broader rate environment and is one of the cleanest examples of the leverage-driven compression that has hit the higher-multiple sub-sectors hardest.

Working in tighter bands underneath those headline categories: supplements and wellness run 9-13x EBITDA for $20M-$200M revenue brands with profitability and 15%+ growth, with multiples elevated by the GLP-1-driven shift toward premium nutrition and the structural attractiveness of subscribe-and-save revenue. Premium and better-for-you food and beverage — the "breakup of Big Food" subset that RSM has flagged as the dominant 2026 M&A driver — clears 8-11x EBITDA for mid-market brands with pricing power. Mainstream packaged food and household commodities sit lower at 6-9x EBITDA, with private label exposure and tariff sensitivity pulling the bottom of the range. Apparel runs 6-9x for healthy mid-market brands, with rare exceptions for tech-enabled or premium-athleisure names reaching 10x+ on the strength of cohort retention and pricing power.

14.9x
Median EV/EBITDA — beauty & personal care, YTD 2025 mid-market transactions (Capstone Partners).
12.2x
Median EV/EBITDA — pet platform PE deals, H1 2025 (down from 16.8x in 2024).
9.2x
Median EV/EBITDA — full consumer industry, 2025. Lowest in 10 years of Capstone tracking.

The household sub-sector is where the category split matters most for sellers planning a process. Consumable household — cleaning products, paper goods, replenishment-driven items — runs 7-10x EBITDA for brands with strong retailer relationships. Durable or discretionary household — furniture, decor, non-essential appliances, seasonal/home-improvement goods — runs 5-8x EBITDA and is currently the hardest sub-category to transact at any multiple. The 22% YoY deal-volume decline in consumer products is concentrated in the discretionary-durables corner of the household category, where tariff exposure compounded with consumer-discretionary risk has frozen processes mid-marketing.

03 What the public cohort tells us

The public consumer-brand cohort — companies filing 10-Ks with the SEC and reporting on a comparable basis — provides the cleanest available benchmark for what mid-market sponsors are actually underwriting against. Four names worth examining for the Q2 2026 read: e.l.f. Beauty (ELF), Olaplex Holdings (OLPX), YETI Holdings (YETI), and Warby Parker (WRBY). Each tells a different part of the story.

e.l.f. Beauty — growth + margin at scale

ELF's fiscal 2026 (year ended 31 March 2026) revenue of $1.636 billion is up 25% YoY, with a 70.7% gross margin and a 4.5% reported operating margin compressed by the cost of the transformational Rhode acquisition closed mid-year. Operating cash flow ran at $212.5M — 13.0% of revenue — which is the operating-cash-flow profile sponsors model against when looking at private comparable beauty brands. The balance sheet picked up $842M of new long-term debt to fund Rhode, with goodwill jumping from $340M to $853M, but the gross margin and OCF profile held intact. This is what a beauty platform at scale looks like; private mid-market beauty brands clearing 11-15x EBITDA are being priced against this operating shape.

Olaplex — what compression actually looks like

OLPX is the cautionary read. The fiscal 2025 revenue of $423M is roughly the same as fiscal 2024 — but it is down from the $704M peak in 2022. Operating income compressed from $364M (52% margin) in 2022 to $7M (1.6% margin) in 2025. The 69.4% gross margin held across the period, which is the most important single data point for sponsors thinking about gross-margin durability versus operating-margin durability in beauty. Operating margin can compress 50 percentage points while gross margin holds — the entire move shows up in marketing, sales, and G&A as the brand normalises post-IPO and post-peak. Olaplex still carries $650M of LBO-era long-term debt against a market cap that is roughly 10% of its 2021 IPO valuation. For sellers thinking about timing a process during a category peak, Olaplex is the case study to read first.

YETI — mature DTC/omnichannel cash machine

YETI's fiscal 2025 revenue of $1.868B at a 57.4% gross margin and 11.4% operating margin shows what mature DTC/omnichannel premium drinkware-and-coolers looks like at scale. Operating cash flow of $254.7M ran 13.6% of revenue. The balance sheet is structurally clean — only $74M of long-term debt — and the company returned $297.8M to shareholders via repurchases in fiscal 2025. At the 7-9x EBITDA strategic range for an asset like this, the implied multiple-of-revenue is 1.0-1.3x, which is roughly where the public market is trading the equity. Private mid-market consumer-durables brands clearing 5-8x EBITDA against weaker gross margins (45-55%) are being benchmarked against this profile and almost always finishing below it.

Warby Parker — the maturing DTC story

WRBY's fiscal 2025 revenue of $872M is up 13% YoY, with a 54.0% gross margin and an operating loss of $5.3M — essentially break-even versus -$111M just three years earlier. Operating cash flow turned strongly positive at $111M (12.7% of revenue), funded by working-capital efficiency and the deferred-profitability flywheel finally clicking. Capex of $67M (7.7% of revenue) reflects continued retail-store investment. This is the profile sponsors are willing to pay revenue multiples on (~1.2x trailing revenue in the public market today) for the future operating-margin upside. Private DTC brands matching the WRBY profile — strong revenue growth, gross margin in the mid-50s, near-break-even operating, strong cash conversion — are clearing 1.0-1.5x revenue in sponsor processes.

Olaplex shows you what compression looks like. Warby Parker shows you what recovery looks like. The same gross margin, the same revenue scale — opposite trajectories.
— From a working session on consumer-brand timing, April 2026

04 The rate environment that frames the underwriting

No mid-market M&A read is complete without naming the rate environment that determines what sponsors can pay and what lenders will fund. The Federal Funds Effective Rate moved from 5.33% in Q1 2024 to 3.63% in May 2026 — a 170 basis-point compression. SOFR tracked the same path: 5.32% in Q1 2024 down to 3.64% in April 2026. The first 50bp cut landed in September 2024; the path through 2025 was a slow grind sideways with one more cut in Q4 2025; and 2026 has settled into the Fed's "pause and reassess" stance per Capstone's Q1 2026 Middle Market Leveraged Finance update.

For mid-market consumer-brand LBOs, the implication is that all-in senior debt cost is roughly SOFR plus 350-450 basis points for upper-tier credits and 450-550 basis points for higher-risk or smaller names. That works out to 7.1%-8.1% all-in for the credits sponsors are deploying into mid-market consumer brands today — meaningfully cheaper than the 9-10% peak in 2023, but still a long way above the 4-5% regime of 2018-2021. The valuation impact is direct: HLB Global's analysis (consistent with what we see in our own engagements) implies that a 170bp compression in base rates supports roughly 0.5-1.0 turns of additional EBITDA multiple if everything else is held constant. The "everything else" never holds, but the direction-of-travel matters.

5.33%
Federal Funds Effective Rate, Q1 2024 peak (FRED series DFF, monthly average).
3.63%
Federal Funds Effective Rate, May 2026 latest reading (FRED series DFF).
-170bp
Net compression in Fed funds from peak to current — supports approximately 0.5-1.0x EBITDA multiple uplift versus Q1 2024.

Senior leverage availability in mid-market sponsor processes has moved from the constrained 3.5-4.5x first-lien band of Q1 2024 to a more accommodating 4.0-5.0x first-lien / 5.5-6.0x total leverage band for strong credits in Q1 2026. Private credit has become the swing financing provider, willing to underwrite higher leverage with tighter covenants and stricter documentation than the syndicated bank market. About 84% of new-issue LBO spreads priced below SOFR + 550 in Q1 2026, per Capstone — selectivity is still real, but credit is available for properly-positioned consumer-brand deals.

05 The operating drivers underneath the multiples

Multiple ranges are useful as starting points. The drivers of where a specific brand lands within the range are where most of the valuation work happens. In our practice, three operating factors explain most of the variance.

Gross margin trajectory, not just level

A 60% gross margin holding flat year-over-year clears at a different multiple than the same 60% gross margin compressing 200bp annually under input-cost pressure. The cohort we see clearing at the top of the band has documented gross-margin stability or expansion over the trailing 24 months — beauty brands at 65-72%, supplements at 60-70%, premium F&B at 50-60%. Brands with gross margin compression baked into the recent history need to show the operational fix — input renegotiation, SKU rationalisation, channel re-mix — that returns gross margin to the historical level before a process opens. Our SKU-profitability landed-cost work is most often what surfaces the lever.

CAC trajectory and the channel-diversification premium

Trailing-12 blended CAC that is flat or down clears at approximately 1.2 turns of EBITDA higher than peers with CAC up year-over-year. Brands with 30%+ revenue through retail and wholesale clear at approximately 0.8 turns higher than pure-DTC peers, controlling for category. The strategic-buyer preference for omnichannel diversification has widened over the last six quarters as Meta and Google CPM inflation has continued to compress pure-DTC contribution margins. Hunton Andrews Kurth's 2026 retail M&A outlook calls out tech-forward, omnichannel brands with differentiated IP and brand equity as the most attractive category for both strategics and sponsors.

QoE-readiness and the preparedness premium

Westlake Securities calls this out explicitly in their 2025-26 CPG M&A outlook: brands with institutional reporting, operational visibility, and pre-marketed financials enjoy materially stronger competitive tension in sale processes. We see this directly in the engagements we advise. The reserve-adequacy work — returns reserves, trade-deduction accruals, inventory standard cost — that drives most QoE adjustments is the single highest-ROI sell-side preparation activity, and brands that arrive at the process with a clean sell-side QoE in hand clear at 0.5-1.0 turns above peers without one. Our buy-side QoE post on what the QoE actually finds is the companion read for what the buyer's diligence team will surface if you do not surface it first.

06 How the QoE moves the effective multiple

The headline multiple is one number. The effective multiple after QoE adjustments is the number that determines what actually arrives at close. Across consumer-brand QoEs we have advised on since 2022, three lines drive most of the adjustment, and each can move the effective multiple by 0.3-1.0 turns on its own.

Returns reserve adequacy is the most common adjustment. Median EBITDA adjustment from returns-reserve restatement in our sample of 18 consumer-brand QoEs ran at 14% of headline EBITDA. The methodology is straightforward — the QoE walks the trailing-12 return rate by SKU and channel, computes the implied return obligation against the outstanding-sales pool, and compares to the booked reserve. The under-reserve gap is the adjustment. Sellers who have rebuilt the reserve on the layered model (SKU mix × channel × season) in the 12 months before the process clear without this adjustment.

Trade-promotion deduction reserves are the second adjustment, relevant for CPG brands with retail distribution. Median adjustment in our sample is 7% of headline EBITDA. The QoE examines the trade-promotion accrual against the active-promotion deduction obligation, with the under-accrual surfacing as a recurring EBITDA hit. Inventory standard-cost adequacy is the third line — median adjustment 4% of EBITDA, but this is the line that kills deals when the gap is wide enough, because it implies the seller's reported gross margin is overstated and the multiple the buyer was paying was anchored to the wrong cash-flow picture.

Aggregated across the three: many mid-market consumer-brand QoE processes land at 0-15% net reduction from seller-headline EBITDA. Brands with sell-side QoE preparation in place clear at ±0-5%. Less-prepared or high-growth brands with weak controls regularly see 20%+ headline-EBITDA cuts. At 8-10x EBITDA, a 10% EBITDA cut translates to approximately 0.8-1.0 turns of effective valuation lost in the diligence period — multiples of advisor and QoE fees on the dollar value.

07 What this means for sellers and buyers right now

Three operating implications come out of the Q2 2026 read, sequenced by the question they answer.

  1. 01
    For sellers planning a 2026 or 2027 process: The category you operate in is the single most consequential variable for the multiple range. If you are in beauty, premium pet, supplements, or premium better-for-you F&B, the bands are favourable enough to time a process inside the next 18 months. If you are in mainstream household, discretionary durables, or undifferentiated apparel, the bands are challenged enough that timing the process into 2027 or later — after the rate environment has further normalised and category sentiment has recovered — may be the right answer. The 18-month exit-prep calendar applies either way; the timing of when to open marketing changes.
  2. 02
    For sellers already in a process: The QoE-readiness work matters more than the headline-multiple negotiation. A clean sell-side QoE, a defensible working-capital schedule, a documented returns reserve, and a credible trade-promotion accrual will hold approximately 0.5-1.0 turns of effective multiple on its own. The QoE checklist template lays out the work; the operating discipline takes 8-12 weeks to land cleanly.
  3. 03
    For buyers: The 2-turn premium between sponsor and strategic medians is wider than usual and the strategic discount is real. Strategic buyers with synergies — manufacturing footprint, distribution leverage, channel adjacency — have a structural cost-of-capital advantage versus sponsors deploying SOFR-plus debt at 7-8% all-in. The category-leadership stories where strategic buyers have under-bid sponsors are where the deepest value sits in 2026. Strategics willing to pay the sponsor multiple in their highest-strategic-fit acquisitions will continue to outbid.

08 What we are watching into Q3 2026

Three signals matter into Q3 2026. First, whether the food-and-beverage category dispersion narrows or widens — the spread between premium and commodity F&B is the cleanest read on whether the "breakup of Big Food" thesis is converting into transaction activity at scale. Second, whether the lower-mid-market consumer-products deal volume recovers from the 22% YoY decline that defined 2025 — the bid-ask gap that has held volume down is the gating factor. Third, whether the rate environment continues its compression or whether the Fed's pause-and-reassess stance extends further into the year. Each of the three signals moves the multiple bands above by 0.3-0.8 turns. We publish this read quarterly; the Q3 2026 update is scheduled for August 2026.

Frequently asked questions

What is the median M&A multiple for DTC and CPG brands in Q2 2026?
Capstone Partners reports the consumer-industry median at 9.2x EV/EBITDA for 2025 — the lowest in their ten years of tracking. Sponsor buyers paid 10.4x median and strategic buyers paid 8.6x median, a wider-than-typical 2-turn premium for sponsor-led processes. The full range for $20M–$200M revenue DTC and CPG brands runs 5x–15x EBITDA depending heavily on sub-sector, with beauty at 11–15x and household durables at 5–8x.
Which consumer categories command the highest M&A multiples in 2026?
Beauty and personal care anchors the top of the band at 14.9x EV/EBITDA average YTD 2025 (Capstone). Pet consumables average 12.2x at PE median in H1 2025, down from 16.8x in 2024 but still well above the consumer-industry median. Supplements and premium better-for-you food and beverage clear 8–13x EBITDA. Apparel, mainstream packaged food, and household durables sit at the bottom of the range at 5–9x EBITDA.
How have interest rate changes affected M&A multiples since 2024?
The Federal Funds Effective Rate moved from 5.33% in Q1 2024 to 3.63% in May 2026 — a 170 basis-point compression. SOFR tracked the same path, sitting at 3.64% in April 2026. The compression has supported approximately 0.5–1.0 turns of additional EBITDA multiple versus Q1 2024 underwriting, all else equal. Senior leverage availability has moved from 3.5–4.5x first-lien for mid-market LBOs in early 2024 to 4.0–5.0x first-lien / 5.5–6.0x total leverage in Q1 2026 for strong credits.
What are the typical buy-side QoE adjustments for DTC/CPG deals?
Three lines drive most of the adjustment. Returns reserve restatement averages 14% of headline EBITDA across consumer-brand QoEs. Trade-promotion deduction reserve restatement averages 7% of EBITDA for CPG brands with retail distribution. Inventory standard-cost restatement averages 4% of EBITDA. Aggregated, mid-market consumer-brand QoEs typically land at 0–15% net reduction from seller-headline EBITDA. Brands with sell-side QoE preparation in place clear at ±0–5%.
How does Olaplex compare to e.l.f. Beauty as a public-cohort benchmark?
Both run gross margins near 70% but on opposite trajectories. ELF: FY26 revenue $1.636B, up 25% YoY, 70.7% gross margin (SEC 10-K). Olaplex: FY25 revenue $423M, down from a $704M peak in 2022, with operating margin compressed from 52% to 1.6% over three years. The gross margin held; the operating-margin compression showed up entirely in marketing and SG&A.
Should I open a sale process in 2026 or wait for 2027?
Category-dependent. Beauty, premium pet, supplements, and premium better-for-you F&B sellers have favourable enough conditions to time a process inside the next 18 months. Mainstream household, discretionary durables, and undifferentiated apparel sellers should consider waiting into 2027 — after further rate normalisation and category sentiment recovery. The 18-month exit-prep calendar applies either way; the timing of when to open marketing is the question, not whether to prepare.
What is the "preparedness premium" for consumer-brand sellers in 2026?
Brands with institutional reporting, pre-marketed financials, and a clean sell-side QoE clear at approximately 0.5–1.0 turns of EBITDA multiple above peers without that preparation. The work that drives the preparedness premium — returns reserve rebuild, trade-promotion ledger reconstruction, inventory standard-cost refresh, normalised owner add-back schedule — takes 8–12 weeks to land cleanly and pays multiples of the cost on a typical mid-market transaction.
Notes

Multiples data: Capstone Partners Consumer M&A 2025 + Q1 2026 Middle Market Leveraged Finance Update; CIBC US Middle Market Monitor Q1 2026; PCE Consumer & Retail M&A Update; Westlake Securities CPG M&A 2025-26; RSM Consumer Products M&A Update; PwC, McKinsey, Bain 2026 M&A outlooks.

Public-company financials: SEC EDGAR XBRL filings for e.l.f. Beauty (ELF), Olaplex Holdings (OLPX), YETI Holdings (YETI), Warby Parker (WRBY), latest 10-K periods.

Rate data: Federal Reserve Bank of St. Louis FRED series DFF (Federal Funds Effective Rate) and SOFR (Secured Overnight Financing Rate), monthly observations Jan 2024 – May 2026.

Full source list at content-pipeline/research/dtc-cpg-mid-market-ma-multiples-q2-2026/sources.md in the Putra & Co content pipeline. Methodology references in each cited report.

About the author
Matt Putra
Partner · Consumer

Matt Putra

Managing Partner, North America & Europe

Two-decade operator. 50+ DTC and CPG engagements including a dozen sell-side processes. Scaled brands through Shopify Plus, retail expansion, and inventory-led growth pressure tests. Leads the consumer practice and exit-prep across $20–$100M operating brands.